Advances in the treatment of small cell lung cancer have been scarce in recent years. Results of second studies now demonstrate a survival advantage for the combination of chemotherapy with immunotherapy.
Advances in the treatment of small cell lung cancer have been scarce in recent years. Results of second studies now demonstrate a survival advantage for the combination of chemotherapy with immunotherapy.
Input your search keywords and press Enter.